🇺🇸 FDA
Patent

US 10080770

Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

granted A61KA61K2300/00A61K2800/87

Quick answer

US patent 10080770 (Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo) held by RegenLab USA LLC expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RegenLab USA LLC
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2300/00, A61K2800/87, A61K35/14, A61K35/15